![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » KING PHARMA ACQUIRES AVINZA FROM LIGAND
KING PHARMA ACQUIRES AVINZA FROM LIGAND
September 11, 2006
King Pharmaceuticals, Inc. has entered into a definitive asset purchase agreement and related agreements with Ligand Pharmaceuticals Incorporated to acquire rights to Avinza (morphine sulfate extended release). Pharmabiz (http://pharmabiz.com/article/detnews.asp?articleid=35044)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct